Mammalian target of rapamycin as a therapeutic target in osteoporosis
Authors:
- 28 September 2017
- journal article
- review article
- Published by Wiley in Journal of Cellular Physiology
- Vol. 233 (5) , 3929-3944
Abstract
The mechanistic target of rapamycin (mTOR) plays a key role in sensing and integrating large amounts of environmental cues to regulate organismal growth, homeostasis, and many major cellular processes. Recently, mounting evidences highlight its roles in regulating bone homeostasis, which sheds light on the pathogenesis of osteoporosis. The activation/inhibition of mTOR signaling is reported to positively/negatively regulate bone marrow mesenchymal stem cells (BMSCs)/osteoblasts‐mediated bone formation, adipogenic differentiation, osteocytes homeostasis, and osteoclasts‐mediated bone resorption, which result in the changes of bone homeostasis, thereby resulting in or protect against osteoporosis. Given the likely importance of mTOR signaling in the pathogenesis of osteoporosis, here we discuss the detailed mechanisms in mTOR machinery and its association with osteoporosis therapy.Keywords
Funding Information
- National Natural Science Foundation of China (81503591, 81674000)
- Natural Science Foundation of Guangdong Province (2016A030313645, 2014A030310082)
This publication has 173 references indexed in Scilit:
- Incidence and Risk of Treatment-Related Mortality with mTOR Inhibitors Everolimus and Temsirolimus in Cancer Patients: A Meta-AnalysisPLOS ONE, 2013
- A novel library screen identifies immunosuppressors that promote osteoblast differentiationBone, 2012
- Cell autonomous requirement of connexin 43 for osteocyte survival: Consequences for endocortical resorption and periosteal bone formationJournal of Bone and Mineral Research, 2011
- Erythropoietin mediated bone formation is regulated by mTOR signalingJournal of Cellular Biochemistry, 2011
- mTOR Complex 1 Regulates Lipin 1 Localization to Control the SREBP PathwayCell, 2011
- The amazing osteocyteJournal of Bone and Mineral Research, 2010
- Autophagy: cellular and molecular mechanismsThe Journal of Pathology, 2010
- Rapamycin versus methotrexate in early diffuse systemic sclerosis: Results from a randomized, single‐blind pilot studyArthritis & Rheumatism, 2009
- The effect of rapamycin on bone growth in rabbitsJournal of Orthopaedic Research, 2009
- A Mammalian microRNA Expression Atlas Based on Small RNA Library SequencingCell, 2007